Biossil Inc.

Industry · 2 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Not Yet Recruiting	Efficacy and Safety of SIL-8301 for Control of Hemolysis in a Uniform Sickle Cell Disease Endotype Sickle Cell Disease, Sickle Cell Anaemia, Sickle Cell Anemia	Phase 2	2026-01-01
Completed	Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subject Anemia, Sickle Cell	Phase 3	2015-06-17